The Business Research Company’s Animal Testing And Non-Animal Alternative Testing Market Report – Opportunities And Strategies – Global Forecast To 2035
LONDON, GREATER LONDON, UK, December 18, 2020 /EINPresswire.com/ — Avail up to 50% off on ALL research reports at: https://www.thebusinessresearchcompany.com/global-market-reports. Offer applies until Dec 31st.
The animal testing and non-animal alternative testing market size is divided into two. The global animal testing market size was valued at $10.74 billion in 2019 and the market is expected to grow at a CAGR of 4.27% during 2019-2025 and at a CAGR of 2.46% during 2025-2035. On the other hand, the global non-animal alternatives testing market was valued at $1.11 billion in 2019. The market is expected to grow at a CAGR of 10.40% during 2019-2025 and at a CAGR of 11.62% during 2025-2035.
End-use industries including cosmetics, pharmaceutical, medical devices, chemicals, and food companies are increasingly seeking partnerships and collaborations with the organizations involved in developing non-animal alternative testing technologies. Collaborations of these end-use companies with leading scientists, academic research institutions, government agencies, and non-profit organizations help them better understand the industry requirements and bottlenecks in the deployment of these alternative technologies. For instance, Unilever has collaborated with the US Environmental Protection Agency (EPA) to develop alternatives to animal testing strategies. Since 2013, AstraZeneca has been collaborating with Emulate, Inc. to develop organ-on-chip technology, which is expected to reduce the use of animals in research as well as the cost and time of discovery and development. In a similar way, Estee Lauder Companies recently expanded its partnership with cruelty-free international and humane society international to end animal testing in cosmetics.
The non-animal alternative testing market size will gain the most in Europe at $0.46 billion in 2025 and $1.45 billion in 2035. Market-trend-based strategies for the non-animal alternatives testing market include collaborating with end users to understand the industry requirements and bottlenecks, and focusing on developing testing methods for the cosmetics industry to capitalize on increasing demand from it. Player-adopted strategies in the non-animal alternative testing market include developing strategic partnerships and collaborations to expand R&D operations.
Here Is A List Of Similar Reports By The Business Research Company:
Organ-On-Chips Market – By Models (Lung-On-Chip, Heart-On-Chip, Liver-On-Chip, Intestine-On-Chip, Kidney-On-Chip And More), By Applications, And By Region, Opportunities And Strategies – Global Forecast To 2023
Pharmaceuticals Market – By Type (Pharmaceutical Drugs, Biologics), By Type Of Pharmaceutical Drugs (Cardiovascular Drugs, Dermatology Drugs, Gastrointestinal Drugs, Genito-Urinary Drugs, Hematology Drugs, Anti-Infective Drugs, Metabolic Disorder Drugs, Musculoskeletal Disorder Drugs, Central Nervous System Drugs, Oncology Drugs, Ophthalmology Drugs, Respiratory Diseases Drugs), By Type Of Biologics Drugs (Monoclonal Antibodies (MAbS), Therapeutic Proteins, Vaccines), And By Region, Opportunities And Strategies – Global Forecast To 2030
Personal Care Services Market – By Type (Beauty Salons, Spas & Massage, Diet And Weight Reducing Centers, Other Personal Care Services), By End User Location (On Premise, Off Premise), By Age ( Below 15, 15-40, 40-65, Above 65), By Gender (Female, Male), And By Region, Opportunities And Strategies – Global Forecast To 2030
Ethical Food Market Global Report 2020-30: COVID-19 Growth and Change
Interested to know more about The Business Research Company?
The Business Research Company is a market intelligence firm that excels in company, market, and consumer research. Located globally it has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services, chemicals, and technology.